Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Biochem J ; 441(2): 579-90, 2012 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-21955321

RESUMEN

Aß42 [amyloid-ß peptide-(1-42)] plays a central role in Alzheimer's disease and is known to have a detrimental effect on neuronal cell function and survival when assembled into an oligomeric form. In the present study we show that administration of freshly prepared Aß42 oligomers to a neuroblastoma (SH-SY5Y) cell line results in a reduction in survival, and that Aß42 enters the cells prior to cell death. Immunoconfocal and immunogold electron microscopy reveal the path of the Aß42 with time through the endosomal system and shows that it accumulates in lysosomes. A 24 h incubation with Aß results in cells that have damaged lysosomes showing signs of enzyme leakage, accumulate autophagic vacuoles and exhibit severely disrupted nuclei. Endogenous Aß is evident in the cells and the results of the present study suggest that the addition of Aß oligomers disrupts a crucial balance in Aß conformation and concentration inside neuronal cells, resulting in catastrophic effects on cellular function and, ultimately, in cell death.


Asunto(s)
Péptidos beta-Amiloides/farmacología , Autofagia/fisiología , Neuroblastoma/patología , Fragmentos de Péptidos/farmacología , Enfermedad de Alzheimer/fisiopatología , Péptidos beta-Amiloides/metabolismo , Catepsina D/metabolismo , Línea Celular Tumoral , Clatrina/metabolismo , Hipocampo/metabolismo , Humanos , Lisosomas/patología , Microscopía Confocal , Microscopía Electrónica de Transmisión , Neuroblastoma/metabolismo , Fragmentos de Péptidos/metabolismo
2.
Prion ; 2(3): 112-7, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-19158505

RESUMEN

Amyloid refers to the abnormal fibrous, extracellular, proteinaceous deposits found in organs and tissues. Amyloid is insoluble and is structurally dominated by beta-sheet structure. Unlike other fibrous proteins it does not commonly have a structural, supportive or motility role but is associated with the pathology seen in a range of diseases known as the amyloidoses. These diseases include Alzheimer's, the spongiform encephalopathies and type II diabetes, all of which are progressive disorders with associated high morbidity and mortality. Not surprisingly, research into the physicochemical properties of amyloid and its formation is currently intensely pursued. In this chapter we will highlight the key scientific findings and discuss how the stability of amyloid fibrils impacts on bionanotechnology.


Asunto(s)
Amiloide/química , Amiloide/metabolismo , Amiloide/toxicidad , Amiloide/ultraestructura , Animales , Humanos , Modelos Moleculares , Nanotecnología , Estructura Cuaternaria de Proteína
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA